Ron Carter

Ron Carter is Chief Medical Officer of Microbiotica. He is experienced in global clinical development strategies, with over 30 years of experience in Europe, the US, Latin America, and Asia. Ron is responsible for progressing the clinical development of the Company’s therapeutics and expanding its clinical footprint beyond the UK.

Ron was previously Chief Medical Officer at Mologen and Indivumed, and earlier, MaaT Pharma, where he progressed full ecosystem microbiome restoration therapy to cancer patients. His most recent role was Interim Senior Medical Director at Seres Therapeutics.

Ron holds an MSc, in Preventive Medicine from Dresden University, Germany, an MD from Hamburg University, and an interdisciplinary Master’s in Public Health (MPH) from UC Berkeley, California.